Skip to content

Clinical trials

Terminated Idiopathic Pulmonary Fibrosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Idiopathic Pulmonary Fibrosis Status: Terminated Country / region: United States Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20082
20093
20101
20111
20122
20132
20151
20161
20174
20185
20193
20202
20212
20222
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated37

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences4
Novartis Pharmaceuticals3
Boehringer Ingelheim2
Celgene2
Hoffmann-La Roche2
InterMune2
Kyntra Bio2
Lakefront Biotherapeutics NV2
Alicia Gerke1
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Idiopathic Pulmonary Fibrosis37
Pulmonary Fibrosis13
Fibrosis7
Lung Diseases, Interstitial6
Idiopathic Interstitial Pneumonias3
Lung Diseases3
Gastroesophageal Reflux2
Hypertension, Pulmonary2
Respiration Disorders2
Asthma1

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.